Abstract
The 18 kDa translocator protein (TSPO) was identified as a discrete receptor for diazepam (1). Since TSPO in the central nervous system (CNS) is believed to regulate neurosteroids biosynthesis, selective TSPO ligands are expected to be useful in the treatment of psychiatric disorders. We synthesized three novel tricyclic benzimidazolone derivatives, and selected the dihydroimidazoquinolinone derivative 27 as a lead TSPO ligand. Study of the structure-activity relationship (SAR) of dihydroimidazoquinolinone derivatives revealed compounds with potent affinity for TSPO (subnanomolar K(i) values), but poor metabolic stability. The optimization of these compounds led to compound 48 with potent affinity for TSPO and good in vitro PK profile.
Copyright © 2013 Elsevier Ltd. All rights reserved.
MeSH terms
-
Acetanilides / chemical synthesis*
-
Acetanilides / chemistry
-
Acetanilides / pharmacokinetics
-
Animals
-
Benzimidazoles / chemical synthesis
-
Benzimidazoles / chemistry*
-
Benzimidazoles / pharmacokinetics
-
Carrier Proteins / chemistry*
-
Carrier Proteins / metabolism
-
Drug Design*
-
Half-Life
-
Heterocyclic Compounds, 3-Ring / chemical synthesis*
-
Heterocyclic Compounds, 3-Ring / chemistry
-
Heterocyclic Compounds, 3-Ring / pharmacokinetics
-
Ligands
-
Male
-
Mice
-
Protein Binding
-
Rats
-
Rats, Sprague-Dawley
-
Receptors, GABA-A / chemistry*
-
Receptors, GABA-A / metabolism
-
Structure-Activity Relationship
Substances
-
Acetanilides
-
Benzimidazoles
-
Carrier Proteins
-
Heterocyclic Compounds, 3-Ring
-
Ligands
-
N-methyl-2-(2-oxo-8-(pyridin-3-ylamino)-5,6-dihydro-4H-imidazo(4,5,1-ij)quinolin-1(2H)-yl)-N-phenylacetamide
-
Receptors, GABA-A
-
Tspo protein, rat
-
benzimidazolone